Xochelli Aliki, Sutton Lesley-Ann, Agathangelidis Andreas, Stalika Evangelia, Karypidou Maria, Marantidou Fotini, Lopez Alba Navarro, Papadopoulos Giorgos, Supikova Jana, Groenen Patricia, Boudjogra Myriam, Sundstrom Christer, Ponzoni Maurilio, Francova Hana Skuhrova, Anagnostopoulos Achilles, Pospisilova Sarka, Papadaki Theodora, Tzovaras Dimitris, Ghia Paolo, Pott Christiane, Davi Frederic, Campo Elias, Rosenquist Richard, Hadzidimitriou Anastasia, Belessi Chrysoula, Stamatopoulos Kostas
Institute of Applied Biosciences, CERTH, Center for Research and Technology Hellas, Thessaloniki, Greece; Hematology Department and HCT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
Am J Pathol. 2015 Jun;185(6):1740-8. doi: 10.1016/j.ajpath.2015.02.006. Epub 2015 Apr 2.
To further our understanding about antigen involvement in mantle cell lymphoma (MCL), we analyzed the expression levels of activation-induced cytidine deaminase (AID), a key player in B-cell responses to antigen triggering, in 133 MCL cases; assessed the functionality of AID by evaluating in vivo class switch recombination in 52 MCL cases; and sought for indications of ongoing antigen interactions by exploring intraclonal diversification within 14 MCL cases. The AID full-length transcript and the most frequent splice variants (AID-ΔE4a, AID-ΔE) were detected in 128 (96.2%), 96 (72.2%), and 130 cases (97.7%), respectively. Higher AID full-length transcript levels were significantly associated (P < 0.001) with lack of somatic hypermutation within the clonotypic immunoglobulin heavy variable (IGHV) genes. Median AID transcript levels were higher in lymph node material compared to cases in which peripheral blood was analyzed, implying that clonal behavior is influenced by the microenvironment. Switched tumor-derived IGHV-IGHD-IGHJ transcripts were identified in 5 of 52 cases (9.6%), all of which displayed somatic hypermutation and AID-mRNA expression. Finally, although most cases exhibited low levels of intraclonal diversification, analysis of the mutational activity revealed a precise targeting of somatic hypermutation indicative of an active, ongoing interaction with antigen(s). Collectively, these findings strongly allude to antigen involvement in the natural history of MCL, further challenging the notion of antigen naivety.
为了进一步了解抗原在套细胞淋巴瘤(MCL)中的作用,我们分析了133例MCL病例中激活诱导的胞苷脱氨酶(AID)的表达水平,AID是B细胞对抗原触发反应中的关键因子;通过评估52例MCL病例中的体内类别转换重组来评估AID的功能;并通过探索14例MCL病例中的克隆内多样化来寻找正在进行的抗原相互作用的迹象。在128例(96.2%)、96例(72.2%)和130例(97.7%)病例中分别检测到了AID全长转录本以及最常见的剪接变体(AID-ΔE4a、AID-ΔE)。AID全长转录本水平较高与克隆型免疫球蛋白重链可变区(IGHV)基因内缺乏体细胞超突变显著相关(P < 0.001)。与分析外周血的病例相比,淋巴结组织中的AID转录本水平中位数更高,这意味着克隆行为受微环境影响。在52例病例中的5例(9.6%)中鉴定出了转换的肿瘤来源的IGHV-IGHD-IGHJ转录本,所有这些转录本均表现出体细胞超突变和AID-mRNA表达。最后,尽管大多数病例显示出低水平的克隆内多样化,但对突变活性的分析揭示了体细胞超突变的精确靶向,表明与抗原存在活跃的、正在进行的相互作用。总的来说,这些发现强烈暗示抗原参与了MCL的自然病程,进一步挑战了抗原幼稚的概念。